Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Metabolic Syndrome and Related Disorders is Scopus-indexed (Q2, CiteScore 3.5), WoS SCIE. Published by SAGE Publications Ltd.
Checked against the index lists dated .
ISSN 1540-4196Verify ISSN ↗1557-8518Verify ISSN ↗
Publisher: SAGE Publications Ltd
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Internal Medicine | 82 / 179 | 54th | Q2 |
| Endocrinology, Diabetes and Metabolism | 150 / 250 | 40th | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2003–present, best quartile Q2, CiteScore 3.5.
Metabolic Syndrome and Related Disorders is Q2 in Internal Medicine (rank 82 of 179) and Q3 in Endocrinology, Diabetes and Metabolism (rank 150 of 250), by CiteScore 2025.
Metabolic Syndrome and Related Disorders is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 3.5, which places it in quartile Q2 at the 54th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.548, quartile Q2, with an H-index of 65.
Metabolic Syndrome and Related Disorders is published by SAGE Publications Ltd. Its print ISSN is 1540-4196 and its online ISSN is 1557-8518.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Metabolic Syndrome and Related Disorders has an h-index of 74 and a 2-year mean of 1.71 citations per paper (OpenAlex). Its Scopus CiteScore is 3.5, quartile Q2. On 2-year citations it ranks #83 of 172 Scopus journals in Internal Medicine.
Metabolic Syndrome and Related Disorders published 47 papers in 2025; its busiest recent year was 2024 with 88. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 98 research articles (2024–2026), authors are most often from China (23%), Türkiye (18.4%) and United States (17.7%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 2 retracted papers are recorded (1.3 per 1,000 papers). The Problematic Paper Screener flags 2 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.